Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Listì

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Critical Reviews in Oncology/Hematology|November 9, 2016
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?Giuseppe Bronte, Lorena Incorvaia, Sergio Rizzo, et al.
Cancers|June 2, 2021
Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-MutationsPaolo Bironzo, Maria Lucia Reale, Tessa Sperone, et al.
Frontiers in Immunology|May 25, 2026
A blood-based immune-suppressive index stratifies immunotherapy outcomes in advanced NSCLCLuca Lalli, Veronica Huber, Agata Cova, et al.
Advances in Therapy|August 22, 2019
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, et al.
Therapeutic Advances in Medical Oncology|April 26, 2019
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patientsFrancesco Passiglia, Antonio Galvano, Marta Castiglia, et al.
Virchows Archiv : an International Journal of Pathology|January 9, 2021
Primary lung adenocarcinoma in three adolescent patients affected by bone sarcomasLuisella Righi, Alberto Righi, Simona Vatrano, et al.
Oncotarget|July 5, 2016
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagusDaniela Cabibi, Stefano Caruso, Viviana Bazan, et al.
Critical Reviews in Oncology/Hematology|March 21, 2021
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspectiveUmberto Malapelle, Sara Pilotto, Francesco Passiglia, et al.
The Journal of Liquid Biopsy|May 8, 2026
Exploring genomic analysis and methylome profiling in longitudinal series of p.G12C KRAS mutated NSCLC patients treated with sotorasibFrancesco Pepe, Francesco Passiglia, Claudia Scimone, et al.
Analytical Cellular Pathology (Amsterdam)|October 21, 2015
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?Daniele Fanale, Giuseppe Bronte, Francesco Passiglia, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Critical Reviews in Oncology/Hematology|November 9, 2016
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?Giuseppe Bronte, Lorena Incorvaia, Sergio Rizzo, et al.
Cancers|June 2, 2021
Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-MutationsPaolo Bironzo, Maria Lucia Reale, Tessa Sperone, et al.
Frontiers in Immunology|May 25, 2026
A blood-based immune-suppressive index stratifies immunotherapy outcomes in advanced NSCLCLuca Lalli, Veronica Huber, Agata Cova, et al.
Advances in Therapy|August 22, 2019
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, et al.
Therapeutic Advances in Medical Oncology|April 26, 2019
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patientsFrancesco Passiglia, Antonio Galvano, Marta Castiglia, et al.
Virchows Archiv : an International Journal of Pathology|January 9, 2021
Primary lung adenocarcinoma in three adolescent patients affected by bone sarcomasLuisella Righi, Alberto Righi, Simona Vatrano, et al.
Oncotarget|July 5, 2016
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagusDaniela Cabibi, Stefano Caruso, Viviana Bazan, et al.
Critical Reviews in Oncology/Hematology|March 21, 2021
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspectiveUmberto Malapelle, Sara Pilotto, Francesco Passiglia, et al.
The Journal of Liquid Biopsy|May 8, 2026
Exploring genomic analysis and methylome profiling in longitudinal series of p.G12C KRAS mutated NSCLC patients treated with sotorasibFrancesco Pepe, Francesco Passiglia, Claudia Scimone, et al.
Analytical Cellular Pathology (Amsterdam)|October 21, 2015
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?Daniele Fanale, Giuseppe Bronte, Francesco Passiglia, et al.
Pageof 4